静脉血栓栓塞症溶栓治疗药物的研究进展  

Advances in the Study of Drugs for Thrombolytic Therapy of Venous Thromboembolism

作　　者：孔玉虎 孙自强[2] 

机构地区：[1]济宁医学院临床医学院,山东 济宁 [2]济宁医学院附属医院血管外科,山东 济宁

出　　处：《临床个性化医学》2024年第4期2519-2524,共6页Journal of Clinical Personalized Medicine

摘　　要：由于生活方式的改变和人口老龄化,静脉血栓栓塞症(VTE)的发病率逐年上升。作为一种严重的血管疾病,静脉血栓栓塞症对健康构成了极大的威胁。溶栓疗法在治疗VTE方面起着至关重要的作用;它能有效地再通血管,减少血栓负荷,并改善患者预后。近年来,治疗VTE的溶栓药物研发取得了重大进展。本文结合临床实践和循证医学的研究结果,对这些溶栓药物进行了探讨,为VTE的临床应用和科学研究提供了参考。The incidence of venous thromboembolism (VTE) is increasing annually due to changing lifestyles and an aging population. As a serious vascular disease, VTE poses significant health risks. Thrombolytic therapy plays a crucial role in treating VTE;it effectively recanalizes blood vessels, reduces thrombus load, and improves patient prognosis. Recent years have seen significant advancements in the development of thrombolytic drugs for VTE. This paper combines findings from clinical practice and evidence-based medicine to discuss these thrombolytic drugs, providing valuable insights for both clinical applications and scientific research on VTE.

关 键 词：溶栓药物 静脉血栓栓塞症 药物治疗 深静脉血栓 

分 类 号：R54[医药卫生—心血管疾病]